Apyx Medical Corp. (APYX) Tops Q1 EPS by 7c ; Offers Guidance

Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $10.77 million.

GUIDANCE:

Apyx Medical Corp. sees FY2026 revenue of $59-60 million, versus the consensus of $57.84 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Evercore ISI Downgrades TE Connectivity (TEL) to In Line